Targeting radiation-resistant hypoxic tumour cells through ATR inhibition

Area of Science:

• Oncology
• Cancer Biology
• Radiotherapy

Background:

• Solid tumors often contain hypoxic regions, making cancer cells resistant to radiotherapy.
• Hypoxic cells are the most aggressive tumor fraction, necessitating targeted treatment strategies.
• Inhibiting the DNA damage response (DDR) is a potential method to sensitize hypoxic tumor cells to radiotherapy.

Purpose of the Study:

• To investigate the cellular effects of ATR kinase inhibition using VE-821 under hypoxic conditions.
• To evaluate the potential of ATR inhibition as a radiosensitizer for hypoxic tumor cells.

Main Methods:

• Utilized a selective ATR inhibitor, VE-821, to study its effects on cancer cells in hypoxic environments.
• Assessed ATR-mediated signaling, DNA damage induction, and cell viability in response to VE-821 and radiation.
• Investigated the link between ATR inhibition and the hypoxic response regulator, HIF-1.

Main Results:

• VE-821 effectively inhibited ATR signaling and induced DNA damage in hypoxic conditions.
• ATR inhibition sensitized various tumor cell lines to radiation across different oxygen tensions.
• VE-821 significantly increased radiation-induced cell death in hypoxic tumor cells.
• Demonstrated a novel link between ATR inhibition and reduced HIF-1 stabilization and activity.

Conclusions:

• ATR inhibition is a promising strategy for targeting tumor cells in pathophysiologically relevant hypoxic conditions.
• Targeting ATR can enhance the efficacy of radiotherapy by sensitizing hypoxic tumor cells.
• This approach offers a novel therapeutic avenue for improving cancer treatment outcomes.